4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001250853-15-000045
Options or other derivatives
- Chief Financial Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Henderson Molly · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-06-08 | Grant or award : show line 1 in the form Stock Option | +200,000 | $10.69 | 2025-06-07 | 200,000 | 200,000 | D |
Loading xslF345X03/primary_doc.xml…